Free Trial
OTCMKTS:CRLBF

Cresco Labs Q2 2025 Earnings Results & Report

Cresco Labs logo
$0.64 -0.01 (-0.79%)
As of 03:59 PM Eastern

Cresco Labs missed analyst earnings expectations but beat on revenue in its Q2 2025 results, released August 7, 2025. The company reported EPS of -$0.05 versus the -$0.04 consensus estimate, while revenue of $163.62 million topped the $162.00 million estimate by $1.62 million.

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
Before Market Opens

Cresco Labs EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.04
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A
EPS Beat Rate
1 of last 8 quarters

Cresco Labs Revenue Results

Actual Revenue
$163.62 million
Expected Revenue
$162.00 million
Beat/Miss
Beat by +$1.62 million
YoY Revenue Growth
N/A

Upcoming Earnings

Cresco Labs' next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules.

Conference Call Resources

Cresco Labs Q2 2025 Earnings FAQ

Cresco Labs (OTCMKTS:CRLBF) reported earnings of -$0.05 per share for Q2 2025, missing the consensus estimate of -$0.04. The report was announced on Thursday, August 7, 2025.

Cresco Labs reported revenue of $163.62 million for Q2 2025, against a consensus estimate of $162.00 million.

Cresco Labs' next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for Cresco Labs on the company's earnings history page.

Cresco Labs Earnings Headlines

Cresco Labs (OTCMKTS:CRLBF) Stock Rating Upgraded by Zacks Research
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
Cresco Labs Inc. (CL:CA): Analysts Forecast Big Upside For Stock
See More Cresco Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cresco Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cresco Labs and other key companies, straight to your email.

About Cresco Labs

Cresco Labs (OTCMKTS:CRLBF) is a vertically integrated cannabis company headquartered in Chicago, Illinois. Founded in 2013, the company cultivates, manufactures and distributes cannabis products for adult-use and medical markets in states where cannabis is legally permitted.

The company’s product portfolio includes flower, pre-rolls, vapes, concentrates, edibles and other cannabis products sold under brands such as Cresco, High Supply, Good News, Wonder Wellness, FloraCal, Remedi and Mindy’s Edibles. Cresco Labs also operates Sunnyside dispensaries, which sell cannabis products directly to consumers.

Cresco Labs serves multiple U.S. cannabis markets, including Illinois and other states with regulated adult-use or medical programs. Its operations generally span cultivation facilities, processing and manufacturing sites, wholesale distribution and retail dispensaries, allowing the company to participate in several stages of the cannabis supply chain.

View Cresco Labs Profile